Patents by Inventor Qwenda LIGON

Qwenda LIGON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200157236
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to ALK, a receptor tyrosine kinase, and modulate the expression and/or activity of ALK. Also provided are uses and methods for treating, e.g., managing, disorders, such as cancer.
    Type: Application
    Filed: August 26, 2016
    Publication date: May 21, 2020
    Applicant: Celldex Therapeutics, Inc.
    Inventors: Diego ALVARADO, Jay LILLQUIST, Qwenda LIGON, Michael FELDHAUS